UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054183
Receipt number R000061873
Scientific Title Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study
Date of disclosure of the study information 2024/04/18
Last modified on 2024/04/18 11:47:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study

Acronym

Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy

Scientific Title

Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study

Scientific Title:Acronym

Ultrasound-guided selective glossopharyngeal nerve block and maxillary nerve block for postoperative analgesia after tonsillectomy: a single-center retrospective study

Region

Japan


Condition

Condition

tonsillectomy

Classification by specialty

Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In recent years, ultrasound-guided selective glossopharyngeal nerve block and ultrasound-guided maxillary nerve block have been reported to be effective for pain management after tonsillectomy. We retrospectively analyzed the effects of UGSGNB and UGMNB on the perioperative management of tonsillectomy under general anesthesia in adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

After recovery from general anesthesia, the patients were transferred to a surgical ward and received standard analgesic treatment with acetaminophen or NSAIDs. Information on the total opioid use, non-opioid analgesic use, and dietary intake were obtained from the patient's medical records.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

This retrospective study evaluated adults who underwent tonsillectomy under general anesthesia at Asahi General Hospital between January 2023 and February 2024.

Key exclusion criteria

Patients who meet any of the following conditions will not be included in this study:
1) Patients who have difficulty communicating due to intellectual disabilities or dementia
2) Other patients who are judged by the research director (co-investigator) to be unsuitable as research subjects.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Kojims

Organization

Asahi General Hospital

Division name

Dental Anesthesiology

Zip code

289-2511

Address

I-1326, Asahi city

TEL

0479-63-8111

Email

cojicoji1109@gmail.com


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Kojima

Organization

Asahi General Hospital

Division name

Dental Anestheisology

Zip code

289-2511

Address

I-1326, Asahi Citry

TEL

0479-63-8111

Homepage URL


Email

cojicoji1109@gmail.com


Sponsor or person

Institute

Asahi General Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahi General Hospital IRB

Address

I-1326, Asahi city

Tel

0479-63-8111

Email

cojicoji1109@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 01 Month 01 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2024 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2024 Year 04 Month 18 Day

Last modified on

2024 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061873


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name